O	0	1	A
O	2	12	randomised
O	13	18	pilot
O	19	24	study
O	25	34	comparing
B-intervention	35	37	13
I-intervention	38	39	G
I-intervention	40	46	vacuum
I-intervention	46	47	-
I-intervention	47	55	assisted
I-intervention	56	62	biopsy
O	63	66	and
B-control	67	79	conventional
I-control	80	82	14
I-control	83	84	G
I-control	85	89	core
I-control	90	96	needle
I-control	97	103	biopsy
O	104	106	of
O	107	115	axillary
O	116	121	lymph
O	122	127	nodes
O	128	130	in
O	131	136	women
O	137	141	with
O	142	148	breast
O	149	155	cancer
O	155	156	.

O	157	159	To
O	160	167	compare
O	168	171	the
O	172	185	acceptability
O	185	186	,
O	187	193	safety
O	193	194	,
O	195	198	and
O	199	210	feasibility
O	211	213	of
O	214	220	vacuum
O	220	221	-
O	221	229	assisted
O	230	236	biopsy
O	237	238	(
O	238	241	VAB
O	241	242	)
O	243	246	and
O	247	251	core
O	252	258	needle
O	259	265	biopsy
O	266	267	(
O	267	270	CNB
O	270	271	)
O	272	274	of
O	275	283	axillary
O	284	289	lymph
O	290	295	nodes
O	296	298	in
O	299	304	women
O	305	309	with
O	310	316	breast
O	317	323	cancer
O	323	324	.

O	325	329	This
O	330	338	parallel
O	338	339	,
O	340	343	non
O	343	344	-
O	344	351	blinded
O	351	352	,
O	353	363	randomised
O	364	369	study
O	370	373	was
O	374	382	approved
O	383	385	by
O	386	389	the
O	390	398	National
O	399	407	Research
O	408	414	Ethics
O	415	422	Service
O	422	423	.

O	424	433	Following
O	434	441	written
O	442	450	informed
O	451	458	consent
O	458	459	,
B-eligibility	460	465	women
I-eligibility	466	470	with
I-eligibility	471	479	abnormal
I-eligibility	480	489	appearing
I-eligibility	490	498	axillary
I-eligibility	499	504	lymph
I-eligibility	505	510	nodes
I-eligibility	511	514	and
I-eligibility	515	529	radiologically
I-eligibility	530	539	malignant
I-eligibility	540	546	breast
I-eligibility	547	553	masses
O	554	558	were
O	559	569	randomised
O	570	571	1
O	571	572	:
O	572	573	1
O	574	576	to
O	577	582	lymph
O	583	587	node
O	588	596	sampling
O	597	602	under
O	603	608	local
O	609	620	anaesthetic
O	621	625	with
O	626	632	either
O	633	635	14
O	636	637	G
O	638	641	CNB
O	642	644	or
O	645	647	13
O	648	649	G
O	650	653	VAB
O	654	656	in
O	657	658	a
O	659	665	single
B-location	666	668	UK
O	669	675	centre
O	675	676	.

O	677	684	Primary
O	685	693	outcomes
O	694	698	were
B-outcome-Measure	699	704	study
I-outcome-Measure	705	711	uptake
I-outcome-Measure	712	716	rate
O	717	720	and
B-outcome-Measure	721	728	patient
I-outcome-Measure	729	740	willingness
I-outcome-Measure	741	743	to
I-outcome-Measure	744	751	undergo
I-outcome-Measure	752	753	a
I-outcome-Measure	754	760	repeat
I-outcome-Measure	761	770	procedure
I-outcome-Measure	771	773	if
I-outcome-Measure	774	783	necessary
O	783	784	.

B-outcome-Measure	785	794	Procedure
I-outcome-Measure	795	803	duration
O	803	804	,
B-outcome-Measure	805	814	immediate
I-outcome-Measure	815	818	and
I-outcome-Measure	819	823	post
I-outcome-Measure	823	824	-
I-outcome-Measure	824	833	procedure
I-outcome-Measure	834	838	pain
I-outcome-Measure	839	845	scores
O	845	846	,
B-outcome-Measure	847	857	diagnostic
I-outcome-Measure	858	863	yield
O	863	864	,
B-outcome-Measure	865	878	complications
O	878	879	,
O	880	883	and
B-outcome-Measure	884	892	surgical
I-outcome-Measure	893	907	histopathology
O	908	912	were
O	913	921	recorded
O	921	922	.

B-total-participants	923	929	Ninety
I-total-participants	929	930	-
I-total-participants	930	934	five
O	935	940	women
O	941	945	were
O	946	956	approached
O	956	957	;
B-total-participants	958	960	81
O	961	962	(
O	962	964	85
O	964	965	.
O	965	966	3
O	966	967	%
O	967	968	)
O	969	978	consented
O	979	982	and
O	983	987	were
O	988	998	randomised
O	998	999	.

B-control-participants	1000	1005	Forty
O	1006	1015	underwent
O	1016	1019	CNB
O	1019	1020	;
B-intervention-participants	1021	1023	40
O	1024	1033	underwent
O	1034	1037	VAB
O	1037	1038	;
O	1039	1042	one
O	1043	1046	was
O	1047	1055	excluded
O	1055	1056	.

O	1057	1063	Median
O	1064	1067	age
O	1068	1071	was
B-age	1072	1074	57
I-age	1075	1080	years
O	1080	1081	.

O	1082	1085	The
O	1086	1092	median
O	1093	1102	procedure
O	1103	1107	time
O	1108	1111	was
O	1112	1113	2
O	1114	1121	minutes
O	1122	1125	for
O	1126	1130	both
O	1131	1141	techniques
O	1141	1142	.

O	1143	1146	The
O	1147	1153	median
O	1154	1160	number
O	1161	1163	of
O	1164	1171	samples
O	1172	1180	obtained
O	1181	1184	was
O	1185	1190	three
O	1191	1194	for
O	1195	1198	CNB
O	1199	1202	and
O	1203	1207	four
O	1208	1211	for
O	1212	1215	VAB
O	1215	1216	.

B-outcome	1217	1223	Median
I-outcome	1224	1228	pain
I-outcome	1229	1235	scores
O	1236	1239	for
O	1240	1243	the
O	1244	1253	procedure
O	1254	1257	and
O	1258	1263	first
O	1264	1265	3
O	1266	1270	days
O	1271	1275	were
B-cv-cont-median	1276	1277	1
O	1277	1278	/
O	1278	1280	10
O	1281	1284	and
B-cv-cont-median	1285	1286	1
O	1286	1287	/
O	1287	1289	10
O	1290	1293	for
O	1294	1297	CNB
O	1298	1301	and
B-iv-cont-median	1302	1303	1
O	1303	1304	/
O	1304	1306	10
O	1307	1310	and
B-iv-cont-median	1311	1312	2
O	1312	1313	/
O	1313	1315	10
O	1316	1319	for
O	1320	1323	VAB
O	1324	1325	(
O	1325	1326	p
O	1326	1327	=
O	1327	1328	0
O	1328	1329	.
O	1329	1331	11
O	1332	1335	and
O	1336	1337	0
O	1337	1338	.
O	1338	1340	04
O	1340	1341	)
O	1341	1342	.

O	1343	1347	More
O	1348	1353	women
O	1354	1358	were
O	1359	1367	prepared
O	1368	1370	to
B-outcome	1371	1378	undergo
I-outcome	1379	1385	repeat
I-outcome	1386	1389	CNB
O	1390	1398	compared
O	1399	1401	to
O	1402	1405	VAB
O	1405	1406	,
O	1407	1410	but
O	1411	1414	the
O	1415	1425	difference
O	1426	1429	was
O	1430	1433	not
O	1434	1445	significant
O	1446	1447	(
B-cv-bin-abs	1447	1449	38
O	1449	1450	/
B-control-participants	1450	1452	39
O	1453	1459	versus
B-iv-bin-abs	1460	1462	33
O	1462	1463	/
B-intervention-participants	1463	1465	39
O	1465	1466	;
O	1467	1468	p
O	1468	1469	=
O	1469	1470	0
O	1470	1471	.
O	1471	1473	11
O	1473	1474	)
O	1474	1475	.

B-iv-bin-abs	1476	1479	Two
O	1480	1488	patients
O	1489	1498	developed
O	1499	1500	a
B-outcome	1501	1510	haematoma
O	1511	1516	after
O	1517	1520	VAB
O	1520	1521	.

B-cv-bin-abs	1522	1525	One
O	1526	1529	CNB
O	1530	1533	and
B-iv-bin-abs	1534	1537	six
O	1538	1542	VABs
B-outcome	1543	1549	failed
I-outcome	1550	1552	to
I-outcome	1553	1558	yield
I-outcome	1559	1567	adequate
I-outcome	1568	1574	tissue
O	1575	1576	(
O	1576	1577	p
O	1577	1578	=
O	1578	1579	0
O	1579	1580	.
O	1580	1582	11
O	1582	1583	)
O	1583	1584	,
O	1585	1588	but
O	1589	1592	the
B-outcome	1593	1604	sensitivity
O	1605	1608	was
O	1609	1616	similar
O	1617	1619	at
B-cv-bin-percent	1620	1622	79
I-cv-bin-percent	1622	1623	%
O	1624	1627	and
B-iv-bin-percent	1628	1630	78
I-iv-bin-percent	1630	1631	%
O	1631	1632	.

B-outcome	1633	1638	Study
I-outcome	1639	1645	uptake
O	1646	1649	was
O	1650	1654	high
O	1654	1655	.

O	1656	1669	Acceptability
O	1670	1672	of
O	1673	1676	the
O	1677	1680	two
O	1681	1691	procedures
O	1692	1695	was
O	1696	1703	similar
O	1703	1704	,
O	1705	1708	but
O	1709	1712	VAB
O	1713	1716	was
O	1717	1727	associated
O	1728	1732	with
O	1733	1737	more
O	1738	1742	post
O	1742	1743	-
O	1743	1752	procedure
O	1753	1757	pain
O	1757	1758	.

O	1759	1762	The
O	1763	1774	sensitivity
O	1775	1782	appears
O	1783	1785	to
O	1786	1788	be
O	1789	1796	similar
O	1796	1797	.
